Early detection of Alzheimer’s disease-related changes in Parkinson’s disease and dementia with Lewy bodies could be made possible by monitoring the amyloid-β (Aβ) and phosphorylated tau (p-tau) proteins.
SciSparc signs patent license deal with Polyrizon for pain therapy
SciSparc will earn royalties from the commercialisation of the pain therapy. Credit: Wasan Tita/Shutterstock. Israel-based pharmaceutical company SciSparc has signed an exclusive patent licence agreement